Antibodies and Vaccines as Drugs for COVID-19

Frontiers Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development - ScienceDirect

Debunking myths about COVID-19 - Mayo Clinic Health System

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine

Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

What Covid Drugs and Vaccines Will Cost Americans in 2023 - Bloomberg

Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario - Ontario COVID-19 Science Advisory Table

Antibodies and Vaccines as Drugs for COVID-19

Vaccines, Free Full-Text

Vaccines Approved and Under Development Against COVID-19

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

9 Things You Need To Know About Molnupiravir, a New COVID-19 Pill > News > Yale Medicine

Research related to COVID-19 (Updated April 1, 2022)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant